Researchers at the University of Pittsburgh report in Science Translational Medicine that nearly all participants in the National Institutes of Health’s All of Us cohort carried at least one pharmacogenomic variant impacting medication processing. About a quarter of those people had been prescribed a drug known to be affected by the variant, supporting expanded testing and prescription decision support.